Christina Louws

Title: Christina Louws: Innovator in Fusion Protein Technology

Introduction

Christina Louws is a notable inventor based in Utrecht, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents to her name, her work focuses on innovative solutions for medical treatments.

Latest Patents

Christina's latest patents include a fusion protein comprising IL-4 and IL-10. This invention involves a fusion protein, a nucleic acid molecule encoding such a fusion protein, a vector comprising the nucleic acid molecule, and a host cell containing the nucleic acid molecule or vector. The invention also outlines a method for producing this fusion protein. The fusion protein or a gene therapy vector encoding it may be utilized in the prevention or treatment of osteoarthritis, chronic pain, and conditions characterized by local or systemic inflammation, immune activation, and/or lymphoproliferation. Another patent focuses on methods of treatment with a fusion protein comprising interleukin 10 and interleukin 4, emphasizing similar applications in medical treatment.

Career Highlights

Throughout her career, Christina has worked with several prominent companies, including Synerkine Pharma B.V. and UMC Utrecht Holding B.V. Her experience in these organizations has allowed her to advance her research and contribute to the field of biotechnology significantly.

Collaborations

Christina has collaborated with notable coworkers such as Joel Adrianus Gijsbert Van Roon and Sarita Aimee Yvonne Hartgring. These collaborations have further enriched her research and development efforts.

Conclusion

Christina Louws stands out as an innovative inventor in the field of fusion protein technology. Her contributions have the potential to impact medical treatments significantly.